Home Infusion for Crohn's Disease: Remicade, Biologics, and What Patients Should Know

April 23, 2026

For many patients with moderate-to-severe Crohn's disease, biologic therapies delivered by IV infusion , most commonly Remicade (infliximab) , are a cornerstone of long-term disease management. Receiving these infusions through home infusion therapy is an option for many stable patients, sparing them repeated trips to an infusion center. Pharmko coordinates this care across 23 states.


How Remicade (Infliximab) Works for Crohn's Disease


Remicade is a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), a protein central to the inflammatory response in Crohn's disease. By neutralizing TNF-α, it reduces intestinal inflammation, helps heal the lining of the bowel, and can achieve and maintain clinical remission in patients who have not responded to conventional therapies.


It is given on a schedule determined by your gastroenterologist , typically at weeks 0, 2, and 6 for induction, followed by maintenance infusions every 8 weeks. For a broader comparison of home infusion approaches vs. clinical settings, see our safety guide.


Other IV Biologics Used in Crohn's Disease


While Remicade is most commonly prescribed, others may be used depending on the patient's disease course:


  • Entyvio (vedolizumab) , targets gut-specific integrin receptors, with a favorable long-term safety profile
  • Tysabri (natalizumab) , used in select cases when other therapies have failed


Your gastroenterologist will determine which biologic is most appropriate for your situation.


Can You Receive Remicade Infusions at Home?


Yes, for many patients. Home infusion of Remicade and other IV biologics is well established, though it requires a few prerequisites: the patient must have received at least their first one to three infusions in a supervised clinical setting to screen for reactions, and must be on a stable maintenance dose.


For patients transitioning from hospital-based infusions, our hospital-to-home transition guide covers what to expect during the changeover and what Pharmko handles on your behalf.


What a Home Remicade Infusion Looks Like


Before the infusion


A Pharmko nurse reviews your current medications, confirms you have no active infections, and takes baseline vital signs. Pre-medications may be administered per your physician's orders to reduce the risk of infusion reactions.


During the infusion


The infusion runs over approximately 2 hours. Your nurse monitors your vital signs at regular intervals and is present to respond immediately if you experience any discomfort or reaction.


After the infusion


Your nurse documents the session and communicates with your gastroenterologist's office. Review which symptoms to watch for in the hours and days following the infusion , and save the number for our 24/7 after-hours support team before your first dose.


Insurance Coverage for Home Remicade Infusions


Remicade is covered by most commercial insurance plans and Medicare Part B under a medical benefit when administered by a licensed provider. Prior authorization is required. Pharmko handles the authorization process and will notify you of any coverage concerns before your first home infusion.


Contact Pharmko to start a referral: 1-877-549-3863

Milrinone Infusion at Home for Heart Failure: Patient Guide and Safety Overview
April 23, 2026
Learn how home milrinone infusion works for advanced heart failure patients, who qualifies for palliative milrinone therapy, what to expect, and how Pharmko supports safe at-home cardiac care.
Malnutrition in Hemodialysis Patients: Signs, Risks, and When IDPN Is Needed
April 23, 2026
Malnutrition affects up to 75% of hemodialysis patients. Learn to recognize protein-energy wasting, understand when IDPN is clinically indicated, and how Pharmko supports renal nutrition management.
IDPN Therapy: Who Qualifies, How It Works, and What to Expect
April 23, 2026
Learn how intradialytic parenteral nutrition (IDPN) works, who qualifies based on albumin levels and nutritional status, and how Pharmko delivers IDPN for dialysis patients.
How to Refer a Patient to Home Infusion Therapy: A Guide for Providers
April 17, 2026
Step-by-step guide for physicians, discharge planners, and case managers on how to refer a patient to home infusion therapy. Learn the process, documentation needed, and what to expect from Pharmko.
Home Infusion vs. Hospital Infusion: Is Receiving IV Therapy at Home Safe?
April 17, 2026
Wondering if home infusion therapy is as safe as hospital infusion? Compare both options, understand the clinical safeguards, and learn when home IV therapy is the right choice.
IVIG Therapy at Home: What Patients Need to Know Before Starting
April 17, 2026
Considering IVIG therapy at home? Learn who qualifies, how home IVIG infusions work, what to expect during treatment, and how Pharmko supports you every step of the way.
Home IV Antibiotics: How to Receive IV Antibiotic Therapy at Home
April 17, 2026
Learn how home IV antibiotic therapy works, who qualifies, what to expect, and how Pharmko supports your treatment from day one. 24/7 clinical support across 23 states.
Home Infusion Binder: Organize Orders, Contacts, and Questions in One Place
April 1, 2026
Learn how to organize home infusion therapy details in one place orders, contacts, supply notes, symptoms, and questions so support is faster and clearer.
Work and School While on Home Infusion: Scheduling, Planning, and What to Ask For
April 1, 2026
Learn how to plan work or school while on home infusion—routine scheduling, communication tips, and what to ask your care team for support.
Comfort During Long Home Infusions: How to Plan Your Setup and Feel Better
April 1, 2026
Learn how to plan comfort during long home infusions—setup, positioning, pacing, and what to track so your care team can support you.
Show More